Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1

Lancet

Volumn 349, Issue 9069, 1996, Pages 1868-1873

  Cohen, Myron S ^a,b   Hoffman, Irving F ^a,b   Royce, Rachel A ^b   Kazembe, Peter ^c   Dyer, John R ^a   Daly, Celine Costello ^d   Zimba, Dick ^c   Vernazza, Pietro L ^e   Maida, Martin ^c   Fiscus, Susan A ^a   Eron Jr , Joseph J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Lilongwe Central Hospital   (Malawi)

^d JOHN SNOW INC   (United States)

^e CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; VIRUS RNA;

AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC THERAPY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SPERM; URETHRITIS; VIRUS CONCENTRATION; VIRUS TRANSMISSION;

EID: 0030604562     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)02190-9     Document Type: Article

References (34)

1. 1 Quinn TC. Global burden of the HIV pandemic. Lancet 1996; 348: 99-106.
2. 2 Garnett GM, Anderson RM. Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J AIDS Hum Retrovir 1995; 9: 500-13.
3. 3 Merson MH. Slowing the spread of HIV: agenda for the 1990s. Science 1993; 260: 1266-68.
4. 4 Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
5. 5 Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill Criteria. Sex Transm Dis 1996; 23: 429-40.
6. 6 Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-36.
7. 7 Kiviat NB, Paavonen JA, Wolner-Hanssen P, et al. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol 1990; 21: 831-37.
8. 8 Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995; 172: 1469-74.
9. 9 Atkins MC, Carlin EM, Emery VC, Griffiths PD, Boag F. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996; 313: 341-42.
10. 10 Eron JJ, Gilliam B, Fiscus S, Dyer J, Cohen MS. HIV-1 shedding and chlamydial urethritis. JAMA 1996; 275: 36.
11. 11 Kreiss J, Willerford D, Hensel M, et al. Association between cervical inflammation and cervical shedding of HIV DNA. J Infect Dis 1994; 170: 1597-601.
12. 12 Lule G, Behets FM-T, Hoffman IF, et al. STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med 1994; 70: 384-88.
13. 13 Behets FM-T, Liomba G, Lule G, et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J Infect Dis 1995; 171: 451-55.
14. 14 Vernazza PL, Eron JJ, Cohen MS, van der Horst CM, Troiani L, Fiscus SA. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994; 8: 1325-29.
15. 15 Dyer JR, Gilliam BL, Eron JJ, Grosso L, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA™ with Amplicor™ reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 1996; 60: 161-70.
16. 16 Zhu T, Wang N, Carr A, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996; 70: 3098-107.
17. 17 Busch MP, Operskalski EA, Mosley JW, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. J Infect Dis 1996; 174: 26-33.
18. 18 Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995; 92: 12100-04.
19. 19 Lee T-H, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J AIDS Hum Retrovir 1996; 12: 427-28.
20. 20 Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240-44.
21. 21 Clerici M, Giorgi JV, Chou C-C, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165: 1012-19.
22. 22 Fowke KR, Nagelkerke JD, Kimani J, et al. Resistance of HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348: 1347-51.
23. 23 Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV-1. N Engl J Med 1997; 337: 1072-78.
24. 24 Gobbers E, Hilgers P, Fransen K, van de Wiel P, van der Groen G. Sensitivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 genotypes. In: Abstracts of the XIth International Conference on AIDS, Vancouver, July 7-12, 1996 (abstr).
25. 25 Vernazza P, Gilliam BL, Dyer J, et al. Quantitation of HIV in semen: correlation with antiviral therapy and immune status. AIDS (in press).
26. 26 Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172: 186-91.
27. 27 Ho JL, He S, Hu A, et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181: 1493-505.
28. 28 Haizlip J, Isbey SF, Hamilton HA, et al. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy. Sex Transm Dis 1995; 22: 145-48.
29. 29 Gilliam BL, Dyer JR, Fiscus SA, et al. Effects of reverse transcriptase inhibitor therapy on HIV-1 viral burden in semen. J Acquir Immun Defic Syndr Hum Retrovirol (in press).
30. 30 Krieger JN, Coombs RW, Collier AC, et al. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol 1995; 154: 1035-40.
31. 31 Speck CE, Coombs R, Koutsky L, et al. Rates and determinants of HIV shedding in semen. XIth International Conference on AIDS; Vancouver, 1996 (abstr We.C.334).
32. 32 Eron JJ, Dyer JR, Hoffman IF, et al. High levels of HIV-1 in semen and blood of seropositive men in Malawi. In: Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, January, 1997 (abstr 26).
33. 33 Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344: 246-48.
34. 34 Kissinger P, Clark R, Dumeste J, Bessinger BA. Incidence of three sexually transmitted diseases during a safer sex promotion program for HIV-1 infected women. J Gen Intern Med 1996; 11: 750-52.